Marinus Pharmaceuticals
Why Robinhood?
You can watch MRNS and buy or sell other stocks, ETFs, and their options commission-free!About MRNS
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.
MRNS Key Statistics
Stock Snapshot
As of today, Marinus Pharmaceuticals(MRNS) shares are valued at $0.55. The company's market cap stands at 29.63M, with a P/E ratio of -0.22.
On 2026-03-10, Marinus Pharmaceuticals(MRNS) stock opened at —, reached a high of —, and a low of —.
The Marinus Pharmaceuticals(MRNS)'s current trading volume is 0, compared to an average daily volume of 333.56K.
In the last year, Marinus Pharmaceuticals(MRNS) shares hit a 52-week high of $10.50 and a 52-week low of $0.22.
In the last year, Marinus Pharmaceuticals(MRNS) shares hit a 52-week high of $10.50 and a 52-week low of $0.22.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.